Incidence and significance of Aspergillus cultures following liver and kidney transplantation. Read more about Incidence and significance of Aspergillus cultures following liver and kidney transplantation.
Fibrosing cholestatic hepatitis in renal transplant recipients. Read more about Fibrosing cholestatic hepatitis in renal transplant recipients.
A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Read more about A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
The use of the T tube after orthotopic liver transplantation. Read more about The use of the T tube after orthotopic liver transplantation.
Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies. Read more about Inhibition of transplant rejection following treatment with anti-B7-2 and anti-B7-1 antibodies.
Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients. Read more about Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients.
Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation. Read more about Renal transplantation without chronic immunosuppression after T cell-depleted, HLA-mismatched bone marrow transplantation.
FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Read more about FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors Read more about The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Read more about The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.
